- Home
- A-Z Publications
- Combinatorial Chemistry & High Throughput Screening
- Previous Issues
- Volume 4, Issue 3, 2001
Combinatorial Chemistry & High Throughput Screening - Volume 4, Issue 3, 2001
Volume 4, Issue 3, 2001
-
-
Post-Panning Computer-Aided Analysis of Phagotope Collections Selected with Neurocysticercosis Patient Polyclonal Antibodies Separation of Disease-Relevant and Irrelevant Peptide Sequences
Authors: K.G. Gazarian, M.J. Rowley, T.G. Gazarian, J. Sotelo, E.G. Mendoza and R. HernandezThe homology of peptide sequences selected from a 7mer phage display library with antibodies elicited by the multicelled parasite Taenia solium in cerebrospinal fluid and serum of neurocysticercosis (NCC) patients and by antibodies of uninfected control patients with similar neurological complications of other ethiology (non-NCC) were analyzed using a PILEUP-Tudos sequence alignments program. The analysis generated Read More
-
-
-
Identification of Inhibitors of DNA Topoisomerase II from a Synthetic Library of Glycoconjugates
Authors: R.P. Tripathi, S.K. Rastogi, B. Kundu, J.K. Saxena, V.J. M. Reddy, S.K. Srivastava, S. Chandra and A.P. BhaduriA library of 24 glycoconjugates related to glycosylated b-amino acid derivative (I) was been prepared and screened against DNA topoisomerase-II of the filarial parasite S. cervi. Among these, compound 6 was found to be a potent inhibitor of DNA topoisomerase-II with 95percent inhibition at 1.0?mM. Furthermore, compound 6 was at least three times more potent than the lead compound, glycosylated b-amino acid derivative I.
-
-
-
In Vitro High Throughput Screening of Compounds for Favorable Metabolic Properties in Drug Discovery.
Authors: C.M. Masimirembwa, R. Thompson and T.B. AnderssonDrug metabolism can have profound effects on the pharmacological and toxicological profile of therapeutic agents. In the pharmaceutical industry, many in vitro techniques are in place or under development to screen and optimize compounds for favorable metabolic properties in the drug discovery phase. These in vitro technologies are meant to address important issues such as (1) is the compound a potent inhibitor of dru Read More
-
-
-
Cystic Fibrosis and Fragile X Syndrome The Arguments for Antenatal Screening.
More LessThe ultimate public health aim of genetic screening is prevention. This can be achieved by reducing birth prevalence through primary or secondary methods such as pre-conceptional or antenatal screening. Tertiary prevention by neonatal screening is also an option where there is direct unbiased evidence for a substantial improvement in prognosis. In addition to this, the information provided during screening is also of va Read More
-
-
-
Combinatorial Chemistry A Tool for the Discovery of New Catalysts.
By H. WennemersThe discovery of new reactions and catalysts has always presented an intriguing challenge to scientists. With the rise of combinatorial chemistry, a new method has emerged that holds considerable promise to facilitate the task since it allows for the simultaneous generation and testing of a large number of compounds. The crucial difficulty lies in establishing general technologies for rapid and reliable screening of libraries to Read More
-
-
-
On-line Sample Preparation for High Throughput Reversed-phase LC / MS Analysis of Combinatorial Chemistry Libraries.
Authors: L. Tang, W.L. Fitch, P. Smith, D. Tumelty, K. Cao and S.W. FerlaAn on-line sample preparation method utilizing a time-programmed autosampler is described for high throughput liquid chromatography / mass spectrometry (LC / MS). This approach is particularly helpful for the LC / MS analysis of samples which require solvents incompatible with HPLC in the sample preparation process. The on-line sample preparation approach minimizes a bottleneck in throughput and improves sample r Read More
-
-
-
Virtual Darwinian Drug Design QSAR Inverse Problem, Virtual Combinatorial Chemistry, and Computational Screening.
More LessThe generation of diversity and its further selection by an external system is a common mechanism for the evolution of the living species and for the current drug design methods. This assumption allows us to label the methods based on generation and selection of molecular diversity as Darwinian ones, and to distinguish them from the structure-based, structure-modulation approaches. An example of a Darwinian metho Read More
-
-
-
Estimation of Aqueous Solubility in Drug Design
By J. HuuskonenThe solubility of drugs in water is of central importance in the process of drug discovery and development from molecular design to pharmaceutical formulation and biopharmacy. The ability to estimate the aqueous solubility and other properties of a promising lead compound affecting its pharmacokinetics is a prerequisite to rational drug design, although it has received much less attention than the prediction of drug-rece Read More
-
Volumes & issues
-
Volume 28 (2025)
-
Volume 27 (2024)
-
Volume 26 (2023)
-
Volume 25 (2022)
-
Volume 24 (2021)
-
Volume 23 (2020)
-
Volume 22 (2019)
-
Volume 21 (2018)
-
Volume 20 (2017)
-
Volume 19 (2016)
-
Volume 18 (2015)
-
Volume 17 (2014)
-
Volume 16 (2013)
-
Volume 15 (2012)
-
Volume 14 (2011)
-
Volume 13 (2010)
-
Volume 12 (2009)
-
Volume 11 (2008)
-
Volume 10 (2007)
-
Volume 9 (2006)
-
Volume 8 (2005)
-
Volume 7 (2004)
-
Volume 6 (2003)
-
Volume 5 (2002)
-
Volume 4 (2001)
-
Volume 3 (2000)
Most Read This Month
Article
content/journals/cchts
Journal
10
5
false
en

Most Cited Most Cited RSS feed
-
-
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization
Authors: Joy Concepcion, Krista Witte, Charles Wartchow, Sae Choo, Danfeng Yao, Henrik Persson, Jing Wei, Pu Li, Bettina Heidecker, Weilei Ma, Ram Varma, Lian-She Zhao, Donald Perillat, Greg Carricato, Michael Recknor, Kevin Du, Huddee Ho, Tim Ellis, Juan Gamez, Michael Howes, Janette Phi-Wilson, Scott Lockard, Robert Zuk and Hong Tan
-
-
- More Less